These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 33509126)
1. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors. Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126 [TBL] [Abstract][Full Text] [Related]
2. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors. Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor. Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971 [TBL] [Abstract][Full Text] [Related]
4. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511 [TBL] [Abstract][Full Text] [Related]
5. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization. Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089 [TBL] [Abstract][Full Text] [Related]
6. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer. Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857 [TBL] [Abstract][Full Text] [Related]
7. Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains. Nieser M; Henopp T; Brix J; Stoß L; Sitek B; Naboulsi W; Anlauf M; Schlitter AM; Klöppel G; Gress T; Moll R; Bartsch DK; Heverhagen AE; Knoefel WT; Kaemmerer D; Haybaeck J; Fend F; Sperveslage J; Sipos B Neuroendocrinology; 2017; 104(3):302-312. PubMed ID: 27222126 [TBL] [Abstract][Full Text] [Related]
8. Smad4 haploinsufficiency in mouse models for intestinal cancer. Alberici P; Jagmohan-Changur S; De Pater E; Van Der Valk M; Smits R; Hohenstein P; Fodde R Oncogene; 2006 Mar; 25(13):1841-51. PubMed ID: 16288217 [TBL] [Abstract][Full Text] [Related]
9. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect? Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328 [TBL] [Abstract][Full Text] [Related]
10. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours. Scarpa A Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588 [TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype. Feurstein S; Rücker FG; Bullinger L; Hofmann W; Manukjan G; Göhring G; Lehmann U; Heuser M; Ganser A; Döhner K; Schlegelberger B; Steinemann D BMC Genomics; 2014 Sep; 15(1):784. PubMed ID: 25213837 [TBL] [Abstract][Full Text] [Related]
18. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia. Haferlach C; Bacher U; Kohlmann A; Schindela S; Alpermann T; Kern W; Schnittger S; Haferlach T Haematologica; 2011 Jun; 96(6):829-36. PubMed ID: 21422114 [TBL] [Abstract][Full Text] [Related]